What is Rigel Pharmaceuticals's EV / EBITDA?

Rigel Pharmaceuticals (RIGL) reported EV / EBITDA of 4.3× in Q1 2026.

How has Rigel Pharmaceuticals's EV / EBITDA changed year-over-year?

Rigel Pharmaceuticals's EV / EBITDA decreased by 28.3% year-over-year, from 6× to 4.3×.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Rigel Pharmaceuticals (RIGL) EV / EBITDA

Screener

EV / EBITDA at other companies

AmgenAMGN

15.7×+0.7×

Zevra Therapeutics, Inc.ZVRA

7.9×—

Gyre Therapeutics, Inc.GYRE

66.1×+8.1×

Opko HealthOPK

28.5×—

Eton Pharmaceuticals, Inc.ETON

525.2×—

Mirum Pharmaceuticals, Inc.MIRM

1,820.6×—

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$750.37M+25.0%

Enterprise value$794.27M+44.9%

P/E2.1×-4.1×

P/S2.5×+0.3×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Calculated from Rigel Pharmaceuticals’s reported figures.

enterprise value/ebitda=4.3×

Based on the most recent quarter.

The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →

Filed: May 5, 2026, 4:05 PM EDT
Fiscal quarter: Q4 FY2026
Calendar quarter: Q4 2026
Accession: 0001034842-26-000032

FAQ

What is Rigel Pharmaceuticals's EV / EBITDA?: Rigel Pharmaceuticals (RIGL) reported EV / EBITDA of 4.3× in Q1 2026.
How has Rigel Pharmaceuticals's EV / EBITDA changed year-over-year?: Rigel Pharmaceuticals's EV / EBITDA decreased by 28.3% year-over-year, from 6× to 4.3×.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about Rigel Pharmaceuticals's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Rigel Pharmaceuticals RIGL EV / EBITDA

EV / EBITDA at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Rigel Pharmaceuticals's ev / ebitda.